CUSIP: 03759B102
Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,188,106
-
Share change
-
-175,416
-
Total reported value
-
$1,370,101
-
Price per share
-
$0.43
-
Number of holders
-
16
-
Value change
-
-$89,312
-
Number of buys
-
5
-
Number of sells
-
6
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2023
-
Previous quarter:
Q1 2023
Recent filing periods for CUSIP 03759B102:
Institutional Holders of APEXIGEN INC - COM (APGN) as of Q2 2023
As of 30 Jun 2023,
APEXIGEN INC - COM (APGN) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,188,106 shares.
The largest 10 holders included
Decheng Capital Management III (Cayman), LLC, Yu Fan, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, MERCER GLOBAL ADVISORS INC /ADV, NORTHERN TRUST CORP, and TWO SIGMA INVESTMENTS, LP.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.